nach oben

Calcified Tissue International

Erschienen in:

09.02.2017 | Original Research

Stimulation of Osteogenic Differentiation by Saikosaponin-A in Bone Marrow Stromal Cells Via WNT/β-Catenin Pathway

verfasst von: Weiqi Huang, Xiaoling Zheng, Xiaodong Yang, Shicai Fan

Erschienen in: Calcified Tissue International | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Saikosaponin-A (SA), a class of native compound with numerous biological activities, may exert protective effect against postmenopausal bone loss. However, it remains unknown whether SA regulates the osteogenic differentiation of bone marrow stromal cells (BMSCs) in the treatment and prevention of osteoporosis. In this study, BMSCs were treated with various concentrations of SA to stimulate osteogenic differentiation over a 14-day period. Additionally, a canonical ovariectomized (OVX) mouse model was used to evaluate the effect of 3-month SA treatment in preventing postmenopausal osteoporosis. In vitro, we found that SA promotes alkaline phosphatase activity/staining and Alizarin red assay, stimulated the expression of osteogenic markers, i.e., runt-related transcription factor 2 (Runx2), osterix, osteopontin, and osteocalcin (OCN) in BMSCs. In vivo, the trabecular number, trabecular thickness, and trabecular bone mineral density of the distal femoral metaphysis were significantly increased in OVX mice treated intraperitoneally with SA for 3 months compared with OVX mice that not treated with SA. Moreover, the expression of Runx2 and OCN in OVX + SA mice was significantly increased than that in OVX mice. Finally, we found that SA activated the WNT/β-catenin pathway and the expression of several downstream genes including T-cell factor-1 and lymphoid enhancer factor-1. Inhibition of WNT/β-catenin pathway by Dickkopf-related protein 1 blocked the positive role of SA on osteogenesis. Therefore, SA promoted the osteogenic differentiation of BMSCs through WNT/β-catenin signaling.

Meng J, Ma X, Wang N, Jia M, Bi L, Wang Y, Li M, Zhang H, Xue X, Hou Z, Zhou Y, Yu Z, He G, Luo X (2016) Activation of GLP-1 receptor promotes bone marrow stromal cell osteogenic differentiation through β-catenin. Stem Cell Rep 6:633CrossRef

Li SF, Tang JJ, Chen J, Zhang P, Wang T, Chen TY, Yan B, Huang B, Wang L, Huang MJ, Zhang ZM, Jin DD (2015) Regulation of bone formation by baicalein via the mTORC1 pathway. Drug Des Dev Ther 9:5169–5183

Wang D, Ma W, Wang F, Dong J, Wang D, Sun B, Wang B (2015) Stimulation of Wnt/β-catenin signaling to improve bone development by naringin via interacting with AMPK and Akt. Cell Physiol Biochem 36:1563–1576CrossRefPubMed

Li M, Wu W, Tan L, Mu D, Zhu D, Wang J, Zhao B (2015) Low-magnitude mechanical vibration regulates expression of osteogenic proteins in ovariectomized rats. Biochem Biophys Res Commun 465:344–348CrossRefPubMed

Curtis JR, Cai Q, Wade SW, Stolshek BS, Adams JL, Balasubramanian A, Viswanathan HN, Kallich JD (2013) Osteoporosis medication adherence: physician perceptions vs. patients’ utilization. Bone 55:1–6CrossRefPubMedPubMedCentral

Tao X, Qi Y, Xu L, Yin L, Han X, Xu Y, Wang C, Sun H, Peng J (2016) Dioscin reduces ovariectomy-induced bone loss by enhancing osteoblastogenesis and inhibiting osteoclastogenesis. Pharmacol Res 108:90–101CrossRefPubMed

Lewiecki EM (2011) New targets for intervention in the treatment of postmenopausal osteoporosis. Nat Rev Rheumatol 7:631–638CrossRefPubMed

Mulder JE, Kolatkar NS, LeBoff MS (2006) Drug insight: existing and emerging therapies for osteoporosis. Nat Clin Pract Endocrinol Metab 2:670–680CrossRefPubMed

Chen JS, Sambrook PN (2012) Antiresorptive therapies for osteoporosis: a clinical overview. Nat Rev Endocrinol 8:81–91CrossRef

10.

Zhou C, Liu W, He W, Wang H, Chen Q, Song H (2015) Saikosaponin a inhibits RANKL-induced osteoclastogenesis by suppressing NF-kappaB and MAPK pathways. Int Immunopharmacol 25:49–54CrossRefPubMed

11.

Shin JE, Kim HJ, Kim KR, Lee SK, Park J, Kim H, Park KK, Chung WY (2015) Type I saikosaponins a and d inhibit osteoclastogenesis in bone marrow-derived macrophages and osteolytic activity of metastatic breast cancer cells. Evid Based Complement Alternat Med 2015:582437PubMedPubMedCentral

12.

Ye M, Bi YF, Ding L, Zhu WW, Gao W (2016) Saikosaponin a functions as anti-epileptic effect in pentylenetetrazol induced rats through inhibiting mTOR signaling pathway. Biomed Pharmacother 81:281–287CrossRefPubMed

13.

Chen E, Chen J, Cao SL, Zhang QZ, Jiang XG (2010) Preparation of nasal temperature-sensitive in situ gel of Radix Bupleuri and evaluation of the febrile response mechanism. Drug Dev Ind Pharm 36:490–496CrossRefPubMed

14.

Bermejo P, Abad MJ, Diaz AM, Fernandez L, De Santos J, Sanchez S, Villaescusa L, Carrasco L, Irurzun A (2002) Antiviral activity of seven iridoids, three saikosaponins and one phenylpropanoid glycoside extracted from Bupleurum rigidum and Scrophularia scorodonia. Planta Med 68:106–110CrossRefPubMed

15.

Sun Y, Cai TT, Zhou XB, Xu Q (2009) Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis. Int Immunopharmacol 9:978–983CrossRefPubMed

16.

Ma Y, Bao Y, Wang S, Li T, Chang X, Yang G, Meng X (2016) Anti-inflammation effects and potential mechanism of saikosaponins by regulating nicotinate and nicotinamide metabolism and arachidonic acid metabolism. Inflammation 39:1453–1461CrossRefPubMed

17.

Fu Y, Hu X, Cao Y, Zhang Z, Zhang N (2015) Saikosaponin a inhibits lipopolysaccharide-oxidative stress and inflammation in Human umbilical vein endothelial cells via preventing TLR4 translocation into lipid rafts. Free Radic Biol Med 89:777–785CrossRefPubMed

18.

Yu YH, Xie W, Bao Y, Li HM, Hu SJ, Xing JL (2012) Saikosaponin a mediates the anticonvulsant properties in the HNC models of AE and SE by inhibiting NMDA receptor current and persistent sodium current. PLoS One 7:e50694CrossRefPubMedPubMedCentral

19.

Liu YQ, Hong ZL, Zhan LB, Chu HY, Zhang XZ, Li GH (2016) Wedelolactone enhances osteoblastogenesis by regulating Wnt/beta-catenin signaling pathway but suppresses osteoclastogenesis by NF-kappaB/c-fos/NFATc1 pathway. Sci Rep 6:32260CrossRefPubMedPubMedCentral

20.

Du L, Nong MN, Zhao JM, Peng XM, Zong SH, Zeng GF (2016) Polygonatum sibiricum polysaccharide inhibits osteoporosis by promoting osteoblast formation and blocking osteoclastogenesis through Wnt/β-catenin signalling pathway. Sci Rep 6:32261CrossRefPubMedPubMedCentral

21.

Su X, Liao L, Shuai Y, Jing H, Liu S, Zhou H, Liu Y, Jin Y (2015) MiR-26a functions oppositely in osteogenic differentiation of BMSCs and ADSCs depending on distinct activation and roles of Wnt and BMP signaling pathway. Cell Death Dis 6:e1851CrossRefPubMedPubMedCentral

22.

Jackson WM, Nesti LJ, Tuan RS (2012) Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cells Transl Med 1:44–50CrossRefPubMed

23.

Chamberlain G, Fox J, Ashton B, Middleton J (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739–2749CrossRefPubMed

24.

Ma ZP, Liao JC, Zhao C, Cai DZ (2015) Effects of the 1, 4-dihydropyridine L-type calcium channel blocker benidipine on bone marrow stromal cells. Cell Tissue Res 361:467–476CrossRefPubMed

25.

Yao W, Guan M, Jia J, Dai W, Lay YA, Amugongo S, Liu R, Olivos D, Saunders M, Lam KS, Nolta J, Olvera D, Ritchie RO, Lane NE (2013) Reversing bone loss by directing mesenchymal stem cells to bone. Stem Cells 31:2003–2014CrossRefPubMedPubMedCentral

26.

Guan M, Yao W, Liu R, Lam KS, Nolta J, Jia J, Panganiban B, Meng L, Zhou P, Shahnazari M, Ritchie RO, Lane NE (2012) Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med 18:456–462CrossRefPubMedPubMedCentral

27.

Jiang J, Li J, Jia X (2014) The antiosteoporotic activity of central-icaritin (CIT) on bone metabolism of ovariectomized rats. Molecules 19:18690–18704CrossRefPubMed

28.

Sun W, Wang YQ, Yan Q, Lu R, Shi B (2014) Effects of Er-Zhi-Wan on microarchitecture and regulation of Wnt/beta-catenin signaling pathway in alveolar bone of ovariectomized rats. J Huazhong Univ Sci Technolog Med Sci 34:114–119CrossRefPubMed

29.

He G, Guo W, Lou Z, Zhang H (2014) Achyranthes bidentata saponins promote osteogenic differentiation of bone marrow stromal cells through the ERK MAPK signaling pathway. Cell Biochem Biophys 70:467–473CrossRefPubMed

30.

Wang Y, Huang X, Tang Y, Lin H, Zhou N (2016) Effects of panax notoginseng saponins on the osteogenic differentiation of rabbit bone mesenchymal stem cells through TGF-β1 signaling pathway. BMC Complement Altern Med 16:319CrossRefPubMedPubMedCentral

31.

Schilling T, Ebert R, Raaijmakers N, Schutze N, Jakob F (2014) Effects of phytoestrogens and other plant-derived compounds on mesenchymal stem cells, bone maintenance and regeneration. J Steroid Biochem Mol Biol 139:252–261CrossRefPubMed

32.

Siddiqi MH, Siddiqi MZ, Ahn S, Kim YJ, Yang DC (2014) Ginsenoside Rh1 induces mouse osteoblast growth and differentiation through the bone morphogenetic protein 2/runt-related gene 2 signalling pathway. J Pharm Pharmacol 66:1763–1773CrossRefPubMed

33.

Niu Y, Li Y, Huang H, Kong X, Zhang R, Liu L, Sun Y, Wang T, Mei Q (2011) Asperosaponin VI, a saponin component from Dipsacus asper wall, induces osteoblast differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway. Phytother Res 25:1700–1706CrossRefPubMed

34.

Huang Q, Gao B, Wang L, Zhang HY, Li XJ, Shi J, Wang Z, Zhang JK, Yang L, Luo ZJ, Liu J (2015) Ophiopogonin D: a new herbal agent against osteoporosis. Bone 74:18–28CrossRefPubMed

35.

Wang L, Zhang YG, Wang XM, Ma LF, Zhang YM (2015) Naringin protects human adipose-derived mesenchymal stem cells against hydrogen peroxide-induced inhibition of osteogenic differentiation. Chem Biol Interact 242:255–261CrossRefPubMed

36.

Serigano K, Sakai D, Hiyama A, Tamura F, Tanaka M, Mochida J (2010) Effect of cell number on mesenchymal stem cell transplantation in a canine disc degeneration model. J Orthop Res 28:1267–1275CrossRefPubMed

37.

Ying X, Chen X, Feng Y, Xu HZ, Chen H, Yu K, Cheng S, Peng L (2014) Myricetin enhances osteogenic differentiation through the activation of canonical Wnt/β-catenin signaling in human bone marrow stromal cells. Eur J Pharmacol 738:22–30CrossRefPubMed

38.

Tao K, Xiao D, Weng J, Xiong A, Kang B, Zeng H (2016) Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway. Toxicol Lett 240:68–80CrossRefPubMed

39.

Xiao JJ, Zhao WJ, Zhang XT, Zhao WL, Wang XX, Yin SH, Jiang F, Zhao YX, Chen FN, Li SL (2015) Bergapten promotes bone marrow stromal cell differentiation into osteoblasts in vitro and in vivo. Mol Cell Biochem 409:113–122CrossRefPubMed

40.

Marie PJ, Kassem M (2011) Osteoblasts in osteoporosis: past, emerging, and future anabolic targets. Eur J Endocrinol 165:1–10CrossRefPubMed

41.

Ai M, Holmen SL, Van Hul W, Williams BO, Warman ML (2005) Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. Mol Cell Biol 25:4946–4955CrossRefPubMedPubMedCentral

Titel: Stimulation of Osteogenic Differentiation by Saikosaponin-A in Bone Marrow Stromal Cells Via WNT/β-Catenin Pathway
verfasst von: Weiqi Huang
Xiaoling Zheng
Xiaodong Yang
Shicai Fan
Publikationsdatum: 09.02.2017
Verlag: Springer US
Erschienen in: Calcified Tissue International / Ausgabe 4/2017
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI: https://doi.org/10.1007/s00223-017-0242-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Stimulation of Osteogenic Differentiation by Saikosaponin-A in Bone Marrow Stromal Cells Via WNT/β-Catenin Pathway

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2017

Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells

Machine Learning Principles Can Improve Hip Fracture Prediction

Aerobic Endurance Training Does Not Protect Bone Against Poorly Controlled Type 1 Diabetes in Young Adult Rats

Adipokines: A Possible Contribution to Vascular and Bone Remodeling in Idiopathic Pulmonary Arterial Hypertension

Bone Mass and Strength are Significantly Improved in Mice Overexpressing Human WNT16 in Osteocytes

Electrical Stimulation of Denervated Rat Skeletal Muscle Ameliorates Bone Fragility and Muscle Loss in Early-Stage Disuse Musculoskeletal Atrophy

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin